LifeVantage Q3 Revenue Slumps 25% to $43.7M as Dividend Rises 11%
LifeVantage reported Q3 revenue of $43.7 million, down 25.2% year-over-year, with net income per diluted share falling to $0.11 from $0.26 and adjusted EBITDA halving to $3.2 million. The board approved an 11% hike in its quarterly cash dividend to $0.05 per share, payable June 15 to shareholders of record June 1.
1. Third Quarter Fiscal 2026 Results
In the third quarter ended March 31, 2026, revenue fell 25.2% year-over-year to $43.7 million, with Americas sales down 28.9% and Asia/Pacific & Europe sales decreasing 7.7% (8.9% on a constant currency basis). Net income totaled $1.4 million, or $0.11 per diluted share, and adjusted EBITDA declined to $3.2 million from $6.4 million a year earlier.
2. Dividend Increase
The board approved a quarterly dividend of $0.05 per common share, an 11.1% increase from the prior $0.045 per share, payable on June 15, 2026 to shareholders of record as of June 1, 2026.
3. Liquidity and Share Repurchase
Cash generated from operations during the first nine months of fiscal 2026 was $5.5 million versus $10.8 million a year earlier, and cash and cash equivalents stood at $12.5 million as of March 31, 2026 with no debt outstanding. The company repurchased approximately 250,000 shares for $1.6 million in the period, leaving $59.0 million available under its $60 million buyback authorization.